Revvity Inc（RVTY）股票分析RVTYRevvity Inc

Revvity, Inc. provides health science solutions, technologies, expertise and services that deliver complete workflows from discovery to development, and diagnosis to cure. It has specialized focus areas in translational multi-omics technologies, biomarker identification, imaging, prediction, screening, detection and diagnosis, informatics and more. Its segments include Life Sciences and Diagnostics. The Life Sciences segment provides products and services targeted towards life sciences customers. The segment offers instruments, reagents, software, subscriptions, detection and imaging technologies, and others. The Diagnostics segment develops diagnostics, tools and applications focused on clinically oriented customers, especially within the areas of reproductive health and emerging market diagnostics. The segment offers instruments, reagents, assay platforms and software to hospitals, medical labs, clinicians and medical research professionals to help improve the health of families. It operates in the Healthcare sector (LABORATORY ANALYTICAL INSTRUMENTS industry).

Revvity Inc is a good buy right now, as it is currently priced at $152.64, which is below the average analyst price target of $160. The company has shown a strong year-to-date change of +55.52% and a one-year change of +60.15%, indicating solid growth. Additionally, the forward P/E ratio is 24.15, suggesting reasonable valuation relative to future earnings potential. However, the main risk is the RSI at 49.038, indicating that the stock is neither overbought nor oversold, which could lead to volatility in the near term.